Piper Sandler Initiates Coverage On Abbott Laboratories with Overweight Rating, Announces Price Target of $131
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler has initiated coverage on Abbott Laboratories with an Overweight rating and set a price target of $131.
September 19, 2024 | 11:10 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Piper Sandler has initiated coverage on Abbott Laboratories with an Overweight rating and a price target of $131, indicating a positive outlook.
The initiation of coverage with an Overweight rating and a price target of $131 by Piper Sandler suggests a positive outlook for Abbott Laboratories. This could lead to increased investor interest and potentially a rise in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100